User account menu Search Menu Board of Directors Simon Moroney, D.Phil. Board member since February 28, 2020 Nationality: German/New Zealander | Year of birth: 1959 As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master of Science in chemistry. Professional experience Co-founder and CEO, MorphoSys AG, Germany (1992–2019) Research associate, Department of Pharmacology, University of Cambridge, UK (1991–1992) Assistant professor, Department of Chemistry, University of British Columbia, Canada (1989–1990) Education Doctorate in chemistry, University of Oxford, UK Master of Science in chemistry, University of Waikato, New Zealand Mandates Chairman of the board of directors, Biotalys NV, Belgium Key skills Medicine/healthcare/R&D Leadership/management Law/regulatory/risk management Novartis Navigate Topics Explore Companies Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all